Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

15.8%

3 terminated/withdrawn out of 19 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

7 recruiting4 with results

Enrollment Performance

Analytics

N/A
5(33.3%)
Phase 1
4(26.7%)
Phase 2
4(26.7%)
Phase 3
2(13.3%)
15Total
N/A(5)
Phase 1(4)
Phase 2(4)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT02390518Phase 1Recruiting

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Role: collaborator

NCT07410689Not ApplicableNot Yet Recruiting

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

Role: collaborator

NCT05344833Phase 2Recruiting

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

Role: collaborator

NCT01208662Phase 3Active Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Role: collaborator

NCT03422198Phase 3Recruiting

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Role: collaborator

NCT04844528Phase 2Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Role: collaborator

NCT07032584Not ApplicableRecruiting

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

Role: collaborator

NCT02328677Recruiting

ColoCare Study - Colorectal Cancer Cohort

Role: collaborator

NCT04160065Phase 1Completed

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Role: collaborator

NCT06108089Recruiting

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Role: collaborator

NCT02779725Not ApplicableCompleted

SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention

Role: collaborator

NCT02019303Not ApplicableCompleted

Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer

Role: collaborator

NCT03925350Phase 2Unknown

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

Role: collaborator

NCT04060407Phase 1Withdrawn

CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)

Role: collaborator

NCT04089319Not ApplicableTerminated

Acupuncture Combined With Mindfulness: ACUMIND

Role: collaborator

NCT01566682Completed

A Multi-Center Trial of the ProLung Test™

Role: collaborator

NCT01305044Phase 2Completed

The HEALS Project - Health Education and Active Living for Surviving Seniors

Role: collaborator

NCT02294565Phase 1Unknown

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

Role: collaborator

NCT00615329Terminated

Huntsman Biopsy Study

Role: collaborator

All 19 trials loaded